InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,010.60
(
0.87%
)
US TECH 100
16,783.60
(
0.18%
)
Dow Jones
38,239.98
(
0.67%
)
Brent Oil
86.88
(
0.54%
)
Bitcoin
66,171.22
(
-1.03%
)
Post# of 2932
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

willyw

Send PM Follow Ignore
Followers 14
Posts 730
Boards Moderated 0
Alias Born 12/09/2013

willyw

Re: A deleted message

Monday, 10/03/2016 9:47:29 AM

Monday, October 03, 2016 9:47:29 AM

Post# of 2932
Per the AASLD abstracts, I am seeing high cure rates w/ the ABT 493/530 doublet. I am also seeing that latter stage trials are including the compounds, co-formulated.

The genotype 3 data looks really good; lets just say that it would be difficult to improve a G-3 treatment naive without cirrhosis cure rate.
The G-3 naive w/ compensated cirrhosis was good but being studied in 16 weeks of TX, in order to get it closer to the non-cirrhotic results.

I'm uncertain as to how much is permissible to post


By the way... the MRK triplet data looks really good, except for AE events.

I think I see Gilead market share erosion. Market agrees this morning.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Start posting your company's news
Only $200 per official company press release!